The manufacturer was involved in a large-scale recall event earlier this year—now a new issue with a specific prescription ...

Driven by self-medication trends, health-conscious consumers, and innovative formulations, the OTC drugs market thrives on the widespread availabilit ...

Hypertension, also known as high blood pressure, is a growing health concern in the U.S. Around 50% of American adults are affected by it, according to health experts, and it’s estimated that only one ...

Glenmark is set to launch a generic version of Teva’s Adderall tablets in strengths ranging from 5 mg to 30 mg, with distribution set to begin in May 2025. The company will launch ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the upcoming launch of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets (mixed ...

In June 2024, 135 batches of blood pressure medication made by Glenmark Pharmaceuticals were also recalled over fears that the pill capsules won't properly dissolve when ingested by patients.

Glenmark Pharmaceuticals Ltd., one of the Indian drugmakers, said that its US-based subsidiary will bring ADHD treatment tablets into the US market by May 2025. The drug consists of a combination ...

Glenmark Logo. According to IQVIA™ sales data for the 12-month period ending February 2025, the Adderall® Tablets, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg market [3] achieved annual sales of ...

Glenmark's Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 5 mg, 10 mg, 15 mg ...

Glenmark Pharmaceuticals has voluntarily recalled ... Here are four more notes: The Class II recall, initiated March 13, covers 148 lots of tablets and capsules made between 2021 and 2023 ...

Its US arm, Glenmark Pharmaceuticals Inc., based in New Jersey, is pulling back several medicines, including Propafenone Hydrochloride extended-release capsules and Solifenacin Succinate Tablets.

New Jersey-based Glenmark Pharmaceuticals Inc is recalling affected lots of medications like Propafenone Hydrochloride extended-release capsules and Solifenacin Succinate Tablets in America, the USFDA ...